COVID antivirals are recommended for people aged over 70 and those at risk of severe illness. But many older Australians are missing out. Here’s why – and how to fix this problem.
Academic rigour, journalistic flair
Articles on Health economics
Displaying 1 - 20 of 250 articles
A government review into private hospitals has yet to be made public. In the meantime, here’s whether there’s a case for a government bail-out.
More Australians delay or skip dental care because of cost than their peers in most wealthy countries. Adding dental to Medicare wouldn’t be easy, but it would vastly improve Australians’ health.
Patients often bear the cost of unexpected bills for basic preventive services such as wellness visits and cancer screenings.
After months of negotiations between the major parties, the government has announced its new plan for aged care. Here’s what it means for people in residential aged care and their families.
Aged care providers can’t find staff and a crisis is brewing. If the problem isn’t fixed, there are serious risks to quality and access to services for older people who need support.
Vaccination rates vary widely from GP to GP. Here’s why – and what governments need to do about it.
When we mapped where Indigenous Australians are using a program to access free or discounted medicines, we found huge variation around the country. Here’s why that’s a problem.
Medicare encourages providers to deliver more services, not to deliver good quality care. Here’s why that needs to change.
The aim is to make health care affordable and sustainable. Our new research shows how.
The budget sets the foundation for a new approach to community-based mental health care, eases cost-of-living pressures and aims to keep people out of hospital. Will they work? And what’s missing?
Making the wrong decision about how to access care can impact both your health and finances. So what are your options? And what policy reforms are needed to improve affordable access to health care?
Sugary drinks cause weight gain and increase the risk of a range of diseases. But a tax can reduce sales and make us healthier.
This is a structural problem, not something one budget can fix.
Greater payroll taxes for GP clinics means lower profits. Clinics will seek to make up the shortfall in revenue by other means – and this could include reducing the number of patients they bulk bill.
Neither Ozempic nor Wegovy are listed on the PBS to treat obesity. When Wegovy becomes available, users will need to pay the full price. Or should the government subsidise it?
Here’s how we design a fairer pathology system, fit for the 21st century, with no out-of-pocket costs or the public.
Local governments are increasingly buying – and forgiving – their residents’ medical debt.
An inhaler that costs nearly $300 in the US goes for just $9 in Germany. What gives?
National Cabinet is meeting today to discuss hospital funding, and the interconnected issues of NDIS reform and GST allocation. But how are hospitals actually funded? And what’s GST got to do with it?
Top contributors
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Program Director, Health and Aged Care, Grattan Institute
-
Professor of Health Economics and Director, Centre for Health Economics, Monash Business School, Monash University
-
Reader in Health Economics, Centre for Health Economics, University of York
-
Adjunct Associate Professor, Menzies Centre for Health Policy and Economics, University of Sydney
-
Professor of Health Economics, Flinders University
-
Health economist, University of Sydney
-
Professor of Health Economics, The University of Melbourne
-
Professor, Public Service Research, UNSW Sydney
-
Professor of Health Economics and Director, Centre for Health Economics Research and Evaluation, University of Technology Sydney
-
Professor and Director, Macquarie University Centre for the Health Economy, Macquarie University
-
Senior Policy Adviser, National Rural Health Alliance; Adjunct Lecturer, University of Sydney
-
Jim Gillespie is a Friend of The Conversation.
Associate Professor in Health Policy, Menzies Centre for Health Policy & Sydney School of Public Health, University of Sydney
-
Associate Professor in Health Economics, Curtin University
-
Lecturer, Public Sector Finance, University of Canberra
